Intraperitoneal, subcutaneous and intravenous glucagon delivery and subsequent glucose response in rats: a randomized controlled crossover trial

OBJECTIVE: Hypoglycemia is a frequent and potentially dangerous event among patients with diabetes mellitus type 1. Subcutaneous glucagon is an emergency treatment to counteract severe hypoglycemia. The effect of intraperitoneal glucagon delivery is sparsely studied. We performed a direct comparison...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:BMJ Open Diabetes Res Care
Prif Awduron: Dirnena-Fusini, Ilze, Åm, Marte Kierulf, Fougner, Anders Lyngvi, Carlsen, Sven Magnus, Christiansen, Sverre Christian
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMJ Publishing Group 2018
Pynciau:
Metabolism
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6235059/
https://ncbi.nlm.nih.gov/pubmed/30487972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjdrc-2018-000560
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg